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Abstract 34 
 Two ‘alleles' of segment 8 (NS) circulate in non-chiropteran influenza A 35 
viruses. The A-allele is found in avian and mammalian viruses, but the B-allele is 36 
viewed as almost exclusively avian. This might reflect that one or both of its 37 
encoded proteins (NS1 and NEP) are maladapted for replication in mammalian 38 
hosts. To test this, a number of clade A and B avian NS segments were 39 
introduced into human H1N1 and H3N2 viruses. In no case was peak virus titre 40 
substantially reduced following infection of various mammalian cell types. 41 
Exemplar reassortant viruses also replicated to similar titres in mice, although the 42 
avian segment 8s reduced weight-loss compared to the PR8 parent. In vitro, the 43 
viruses coped similarly with type I interferons. Temporal proteomics analysis of 44 
cellular responses to infection showed that the avian NS segments provoked 45 
lower expression of IFN-stimulated genes in cells than the WT. Thus, neither A- 46 
nor B-alleles of avian virus-derived NS segments necessarily attenuate virus 47 
replication in a mammalian host although they can attenuate disease. 48 
Phylogenetic analyses identified 32 independent incursions of an avian-derived 49 
A-allele into mammals compared to 6 introductions of a B-allele. However, A-50 
allele isolates from birds outnumber B-allele samples and the relative rates of 51 
Aves to Mammalia transmission are not significantly different. We conclude that 52 
while the introduction of an avian virus segment 8 into mammals is a relatively 53 
rare event, the dogma of the B-allele being especially restricted is misleading – 54 
with implications in the assessment of pandemic potential of avian influenza 55 
viruses.   56 
57 
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Importance 58 
Influenza A virus (IAV) can adapt to poultry and mammalian species, inflicting a 59 
great socioeconomic burden on farming and healthcare sectors. Host adaptation 60 
likely involves multiple viral factors. Here, we investigated the role of IAV 61 
segment 8. Segment 8 has evolved into two distinct clades – the ‘A’ and ‘B’ 62 
alleles. The B-allele genes have previously been suggested to be avian-63 
restricted. We introduced a selection of avian A- and B-allele segment 8s into 64 
human H1N1 and H3N2 backgrounds, and found that these reassortant viruses 65 
were fully competent in mammalian host systems. We also analysed the currently 66 
available public data on segment 8 gene distribution, finding surprisingly little 67 
evidence for specific avian-host restriction of the B clade segment. We conclude 68 
that B-allele segment 8 genes are in fact capable of supporting infection in 69 
mammals and that they should be considered during the assessment of 70 
pandemic risk of zoonotic influenza A viruses.  71 
72 
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 5
Introduction  73 
Influenza A virus (IAV) belongs to the family Orthomyxoviridae and has a 74 
negative sense RNA genome consisting of 8 single-stranded segments (1).  IAV 75 
is subtyped according to its surface glycoproteins hemagglutinin (HA) and 76 
neuraminidase (NA), of which there are at least 16 and 9 different subtypes, 77 
respectively, in non-chiropteran strains. The natural host of IAV is waterfowl, but 78 
the virus is able to adapt to other avian and mammalian hosts. The virus causes 79 
seasonal epidemics and sporadic pandemics in humans, as well as regular 80 
outbreaks in wild and domestic animals. The determinants that facilitate the 81 
adaptation of an avian IAV to a new host species are, at present, incompletely 82 
understood. Host adaptation is likely influenced by a combination of multiple viral 83 
and host factors. Of the viral factors, the HA protein (2, 3), required for virus entry 84 
into host cells, and the polymerase basic protein 2 (PB2) (4), forming part of the 85 
trimeric RNA-dependent RNA polymerase, are thought to play particularly 86 
important roles in host adaptation, but most viral genes are likely to contribute 87 
(reviewed in (5)). There is currently a global fear that avian influenza strains 88 
which are highly pathogenic in humans will adapt sufficiently to be able to spread 89 
readily within the human population. Thus it is of high importance to improve our 90 
understanding of host adaptation and pathogenicity.   91 
The nonstructural (NS) segment 8 of IAV encodes two major polypeptides 92 
that are expressed in all strains – nonstructural protein 1 (NS1) and the nuclear 93 
export protein (NEP). NS1 is expressed following faithful transcription of the 94 
segment 8 vRNA, while a pre-mRNA splicing event leads to NEP expression (6). 95 
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IAV replicates its genome in the host cell nucleus, and NEP is essential for the 96 
nuclear export of viral ribonucleoproteins prior to virus egression (7).  NEP has 97 
also been implicated in other roles such as regulating viral genome replication (8) 98 
and assisting virus budding (9). NS1 is a multifunctional, dimeric protein, ranging 99 
in size from 215-237 amino acids, that interacts with RNA and a plethora of host-100 
cell proteins in a strain- and host-specific manner to mediate its primary role of 101 
antagonising the host innate immune response (reviewed in (10)). The N-terminal 102 
73 amino acids of NS1 constitute an RNA-binding domain (RBD) that can bind a 103 
variety of both single- and double-stranded RNAs with low affinity (11, 12), and 104 
this is required to inhibit the host antiviral RNase L pathway by preventing 105 
activation of 2’-5’ oligoadenylate synthetase (OAS) (13). C-terminal to the RBD, 106 
connected by a short linker, is an effector domain (ED) that forms interactions 107 
with many host cell factors.  For example, the NS1 protein of many strains binds 108 
and inhibits host 30-kDa cleavage and polyadenylation specificity factor 109 
(CPSF30) to inhibit host cell mRNA processing, thus dampening the innate 110 
immune response (14). The NS1 protein also binds host tripartite motif-containing 111 
protein 25 (TRIM25) and prevents retinoic acid-inducible gene 1 (RIG-I) 112 
ubiquitination following detection of pathogen-associated molecular markers 113 
(PAMPs) and subsequent activation, thus inhibiting the induction of the type I 114 
interferon (IFN) response (15). The products of the NS segment have indeed 115 
been implicated in host adaptation and pathogenicity. For instance, Li et al 116 
concluded the NS1 gene contributed to the virulence of H5N1 avian influenza 117 
viruses (16), while adaptive mutations in both the NS1 and NEP proteins were 118 
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 7
found when A/Hong Kong/1968 (H3N2) was adapted to increased virulence in 119 
mice (17).    120 
The NS segment of non-chiropteran IAV has classically been divided into 121 
two ‘alleles’ based on nucleotide homology – the A- and B-alleles (18), although 122 
recent H17 and H18 bat IAV isolates have initiated the use of the term C-allele 123 
(19-21). There is a striking divergence in the amino acid homology of A- and B-124 
allele NS1 proteins, where identity can be as low as 63% between the lineages, 125 
but is typically above 93% within an allele (22-24).  The A- and B-allele groups 126 
encompass many avian IAV isolates, but historically, all strains isolated from 127 
mammalian hosts, bar one H3N8 equine IAV (25), belonged to the A-allele group. 128 
Plausibly, this seeming bias reflects a host-specific restriction and consistent with 129 
this, there is long-standing evidence that the B-allele of the NS segment 130 
attenuates mammalian-adapted viruses. Treanor et al. generated segment 8 131 
reassortant viruses on the background of the human H3N2 A/Udorn/72 132 
(Udorn72) virus and found that the B-allele reassortant gave significantly reduced 133 
peak titres in the nasopharynx of squirrel monkeys in comparison to an A-allele 134 
counterpart, and also had a shorter duration of shedding (18). More recently, 135 
various B-allele NS1 proteins from avian viruses were found to be less effective 136 
at suppressing the activation of the IFN-β, NF-κB and AP-1 promoters in human 137 
and mink lung cells than A-allele counterparts (26-29). However, the introduction 138 
of a B-allele NS segment from an H5N1 highly pathogenic avian influenza (HPAI) 139 
virus into an HPAI H7N1 background increased virus fitness in mammalian cells 140 
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and allowed productive infection of mice (30). Thus, there are conflicting data in 141 
the literature. 142 
To better elucidate the role of the B-allele NS segment 8 in IAV host 143 
adaption, we introduced a variety of avian influenza A- and B- allele NS 144 
segments into human H1N1 (laboratory-adapted or pdm2009) and H3N2 viruses, 145 
and assessed virus fitness in mammalian systems in vitro and in vivo. We found 146 
no evidence for a B-allele-specific attenuation of IAV replication or pathogenicity. 147 
We performed bioinformatic and phylogenetic analyses on all influenza segment 148 
8 sequences available in GenBank, and estimated the nominal rates of 149 
introduction of avian A- and B-allele NS segments into mammalian hosts. We 150 
propose that these rates are comparable, and that the relative paucity of 151 
mammalian B-allele isolates reflects their lower prevalence in the avian host; a 152 
theory that has implications for the interpretation of surveillance data and 153 
assessment of pandemic risk (31).   154 
155 
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 9
Materials and Methods 156 
Ethics statement 157 
All animal experiments were carried out under the authority of a UK Home Office 158 
Project Licence (60/4479) within the terms and conditions of the strict regulations 159 
of the UK Home Office ‘Animals (scientific procedures) Act 1986’ and the Code of 160 
Practice for the housing and care of animals bred, supplied or used for scientific 161 
purposes. Ethical approval for experiments using human macrophages was 162 
obtained from the Lothian Research Ethics Committee. All subjects provided 163 
written informed consent at each donation.  164 
Cell culture, viruses, plasmids and antibodies. Madin Darby Canine Kidney 165 
(MDCK) cells, human embryonic kidney 293T cells (293T), and human 166 
adenocarcinomic alveolar basal epithelial (A549) cells (Sigma Co.) were grown in 167 
Dulbecco’s Modified Eagle Medium (D-MEM, Sigma Co.) supplemented with 168 
10% (v/v) fetal bovine serum (FBS), 2 mM glutamine, 100 U/ml penicillin, and 169 
100 μg/ml streptomycin (complete D-MEM). Madin Darby Canine Kidney-170 
sialyltransferase 1 (MDCK-SIAT, (32)) cells were cultured as for MDCK cells with 171 
the addition of 1 mg/ml geneticin (Gibco Co.) to culture medium. HEK293-Blue 172 
IFN-α/β cells (HEK-Blue, InvivoGen) were cultured in complete D-MEM 173 
supplemented with 30 μg/ml Blasticidin and 100 μg/ml Zeocin (InvivoGen). 174 
Primary CD14+ human monocytes were isolated from whole blood as described 175 
previously (33). Monocytes were plated in 24-well plates in RPMI supplemented 176 
with 10% FBS (v/v), 2 mM glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin 177 
(Sigma Co.)  and 104 U/ml (100 ng/ml) recombinant human (rh)CSF-1 (a gift from 178 
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 10
Chiron, Emeryville, CA, USA) for 7 days for differentiation into macrophages. 179 
Infections were performed on day 8. 180 
A/Puerto Rico/8/1934 (H1N1) (PR8) (34), A/California/7/2009 (H1N1) (Cal7) and 181 
Udorn72 (H3N2) (35) viruses were generated by reverse genetics essentially as 182 
described previously (36). Briefly, 106 human 293T cells were transfected with 183 
the reverse genetics plasmids (250 ng each), using 4 μl of a cationic lipid mixture 184 
(Lipofectamine 2000 Transfection Reagent, Invitrogen, Life Technologies) 185 
according to manufacturer’s instructions. To generate NS segment reassortants, 186 
the pDUAL plasmid for PR8 segment 8 was replaced with a pHH21 plasmid 187 
containing segment 8 from one of several LPAI strains (Table 1). These plasmids 188 
were constructed with full-length segment 8 cDNA generated by RT-PCR using 189 
LPAI virus RNA (37) and primers (38) following standard protocols (39). 190 
Additional pDUAL plasmids containing segment 8 cDNA from other relevant virus 191 
strains (Table 1) were generated by synthesising full-length segment 8 genes 192 
(Biomatik) and cloning into the pDUAL vector using BsmBI restriction 193 
endonuclease sites (primer sequences are available on request). Where full-194 
length sequences including the segment UTRs were not available, segment 8 195 
termini from the closest relative was used (see Table 1). Any BsmBI DNA 196 
restriction endonuclease sites within the segment 8 cDNA sequence were 197 
synonymously changed to remove the site without altering NS1 or NEP protein 198 
sequence (see Table 1). Cal7 (H1N1) gene segments were amplified by RT-PCR 199 
(primer sequences available on request) and cloned into the pHW2000 vector 200 
(40). On day 2, the media was changed to serum-free D-MEM supplemented with 201 
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 11
0.14 % Bovine Serum Albumin (w/v) and 5 μg/ml L-(tosylamido-2-phenyl) ethyl 202 
chloromethyl ketone (TPCK)-treated trypsin (Worthington Biochemicals) (RG 203 
medium). The supernatant was collected on day 4 and propagated by either 204 
using 0.1 ml of virus-containing supernatant to infect T25 flasks of MDCK cells for 205 
48 h, maintained in 5 ml virus growth medium, or by inoculating 2000 PFU of 206 
virus into the allantoic cavity of 10-day-old embryonated chicken eggs that were 207 
maintained at 37°C for 72 h. Virus was titrated by standard plaque assays on 208 
MDCK or MDCK-SIAT (for Cal7-based viruses) cells. The segment 8 of each 209 
virus was sequence verified.  210 
 Polyclonal rabbit antisera to PR8 NS1 (V29), NEP (V13), nucleoprotein 211 
(NP) (2915) and matrix protein 1 (M1) (2917) have been described previously 212 
(41-44). Polyclonal rabbit antiserum against O265B NS1 residues 211-226 (A2) 213 
was raised by inoculating rabbits with a KHL-peptide conjugate 214 
(CGPPLPPKQKRYMARRV). A mouse monoclonal antibody to influenza A virus 215 
matrix 2 ion channel protein (M2) was purchased from AbCam (ab5416). Rat 216 
monoclonal antibody to tubulin-α was purchased from Serotec (MCA77G, clone 217 
YL1/2).  218 
 219 
Viral protein expression analysis. MDCK cells in 24-well plates were infected 220 
at an MOI of 3 for 8 h and lysed in 200 μL SDS-PAGE loading buffer. Proteins 221 
were separated by SDS-PAGE and transferred to nitrocellulose membranes for 222 
western blotting. Membranes were probed with primary antibody in PBS/0.1 % 223 
(v/v) Tween20. The membranes were then probed with species-specific anti-IgG 224 
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 12
secondary antibodies conjugated to infrared-fluorescent dyes detectable using 225 
the Licor Odyssey system. For radiolabeled immunoprecipitation, cells were 226 
infected at an MOI of 10 and at 4 h p.i. the medium was changed to met-/cys-free 227 
D-MEM containing 5% (v/v) dialysed bovine serum. At 6 h p.i., cells were pulsed 228 
with 0.4 MBq 35S protein labelling mix (PerkinElmer) in met-/cys-free D-MEM. At 229 
8 h p.i., cells were lysed in a 0.1% SDS buffer (100 mM KCl, 50 mM Tris-Cl, pH 230 
7.6, 5 mM MgCl2, 1 mM DTT, 1% Triton X-100, 1% sodium deoxycholate). 231 
Clarified lysates were incubated with rabbit polyclonal antiserum and protein A 232 
agarose (Roche). Immunoprecipitated proteins were eluted by boiling in SDS-233 
PAGE sample buffer, separated by SDS-PAGE, and detected using 234 
autoradiography. For radiolabeling of whole cell lysates, cells were infected at an 235 
MOI of 5 and radiolabelled as above at 8 h p.i. After 1 h, cells were lysed and 236 
protein content analysed by SDS-PAGE and autoradiography.  237 
Type I interferon assays. A549 cells were pre-conditioned with exogenous 238 
human interferon-β (Abcam) for 24 h prior to a multicycle infection (MOI 0.01). At 239 
48 h p.i., cell lysates were generated for western blot analysis of viral NP and 240 
cellular interferon-induced GTP-binding protein Mx-1 (Mx-1), and virus in the 241 
supernatant was titrated by plaque assay. IC90 values were calculated using 242 
GraphPad Prism 6 software.  243 
To assay IFN production, 180 µl of HEK-Blue cell suspension (at 2.8 x 105 244 
cells/ml) was added to 20 µl of UV-treated (120000 μJ/cm2 for 10 min, CL-1000 245 
Ultraviolet Crosslinker, UVP)) sample in 96-well plates and incubated for 24 h at 246 
37°C. 20 µl of HEK-Blue cell supernatant was transferred to 180 µl of Quanti-247 
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 13
Blue substrate (InVivoGen) in a separate 96-well plate and incubated for 1 h at 248 
37°C. Absorbance at 630nm was recorded and used as a read-out for active type 249 
I IFN levels in the initial samples. A standard curve was generated in parallel 250 
using known quantities of human IFN-β. 251 
Human and mouse cytokine protein arrays.  Human MDMs were infected at 252 
an MOI of 1 for 24 h. Cytokine profiling of clarified supernatants was performed 253 
using a human cytokine array kit (R and D Systems Human Cytokine Array Kit, 254 
panel A) using the near-infrared fluorescence detection protocol as instructed by 255 
manufacturer. Lung homogenates from BALB/c mice culled at day 4 p.i. were 256 
pooled, clarified, and cytokine profiling was performed using a mouse cytokine 257 
array kit (R and D Systems Mouse Cytokine Array Kit, Panel A) as above.  258 
Quantitative Proteomics 259 
1 x 107 human lung A549 cells in 100mm x 20mm dishes were infected at an 260 
MOI of 5 for either 8 h, 16 h, or 24 h. Cells were lysed in a 6M guanidine lysis 261 
buffer and lysates were sonicated using a water bath sonicator. Lysates were 262 
clarified by centrifugation at 21000 X g for 10min and were frozen in liquid 263 
nitrogen. Lysates were then processed for mass-spectrometry as previously 264 
described (45). Briefly, protein was digested with LysC then Trypsin. Peptides 265 
were labelled with tandem mass tag (TMT) reagents, and 12 fractions generated 266 
by high pH reversed phase HPLC. Mass spectrometry was performed using an 267 
Orbitrap Fusion, TMT reporter ions were quantified from the MS3 scan (46). 268 
Peptides were identified and quantified using a Sequest-based in-house software 269 
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 14
pipeline. The human Uniprot database was searched, and peptide-spectral 270 
matches were filtered to a 1% False discovery rate (FDR) using linear 271 
discriminant analysis in conjunction with the target-decoy method (47). The 272 
resulting dataset was further collapsed to a final protein-level FDR of 1%. Protein 273 
assembly was guided by principles of parsimony. Proteins were quantified by 274 
summing TMT reporter ion counts across all matching peptide matches after 275 
filtering based on isolation specificity. Reverse and contaminant proteins were 276 
removed, and protein quantitation values were exported for normalisation and 277 
further analysis in Excel. Hierarchical centroid clustering based on uncentered 278 
Pearson correlation was performed using Cluster 3.0 (Stanford University) and 279 
visualized using Java Treeview (http://jtreeview.sourceforge.net).       280 
Competition Assays. MDCK cells were infected with equal PFU of two viruses 281 
and the progeny virus subjected to plaque assay under a 0.6% agarose overlay 282 
for 48h. Individual plaque picks were amplified in MDCK cells and 24 h later, viral 283 
RNA in the supernatant was extracted using Trizol Reagent (Life Technologies) 284 
while the cells were lysed in SDS-PAGE sample buffer. To identify the source of 285 
segment 8, cDNA was synthesised using AMV-RTase (Promega) using a primer 286 
complementary to the 3’ end of PR8 NS segment vRNA 287 
(AGCAAAAGCAGGGTGAC) that also efficiently primes reverse transcription 288 
from segment 8 vRNA of all avian strains used in this report. RT-PCR was 289 
performed using Taq DNA polymerase (Invitrogen) with primers specific for the 290 
NS1 ORF of O175A (Forward: 291 
GCAACCGGTACCATGGATTCCAACACTGTGTC, Reverse: 292 
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 15
GGTTGCACCGGTGTAACTTCTGACTCAATTGTTC) and O265B (Forward: 293 
GCAACCGGTACCATGGACTCCAACACGATAACC, Reverse: 294 
GGTTGCACCGGTGTAACTTCTGACTCAACTCTTC).  Alternatively, the NS1 295 
content of cell lysates was analysed by SDS-PAGE and western blotting, using 296 
the differential reactivity of rabbit polyclonal antisera V29 (detects PR8 and 297 
O175A NS1) and A2 (detects O175A and O265B NS1) to score plaque picks.  298 
Mouse infections. BALB/c mice were purchased from Harlan UK Ltd (Oxon, 299 
UK). All work was carried out under a UK Home Office licence according to the 300 
Animals (Scientific Procedures) Act 1986. Five- to 6-week-old female mice were 301 
anaesthetized using isofluorane (Merial Animal Health Ltd) and infected 302 
intranasally with 500 PFU of virus in 40 μl serum-free D-MEM. Mice were 303 
weighed daily and assessed for visual signs of clinical disease, including 304 
inactivity, ruffled fur and laboured breathing. At days 2, 4, and 6 p.i., mice were 305 
euthanized by CO2 asphyxiation.  The tip of the left lung was harvested into 306 
preservative (RNA later, Life Technologies) prior to RNA extraction, while the 307 
remainder of the left lung was removed, homogenized in serum-free D-MEM and 308 
clarified by centrifugation. Titres of infectious virus in the left lung were 309 
determined by plaque assay on MDCK cells. The lobes of the right lung were 310 
fixed in 10% (v/v) neutral buffered formalin, before being processed then 311 
embedded in paraffin. 5 μm thick sections were cut and stained with 312 
haematoxylin and eosin before being assessed (blinded) by a pathologist (PMB) 313 
and lesions scored. The scoring system was as follows: 0, no lesions; 1, mild, 314 
focal inflammation and rare degeneration and necrosis; 2, moderate, multifocal 315 
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inflammation with frequent necrotic cells; 3, marked, multifocal inflammation with 316 
common necrosis and occasional fibrin accumulation. For immunofluorescence 317 
imaging, lung tissue was deparaffinised and stained for intracellular viral NP 318 
using rabbit polyclonal antiserum (2915). The lung tissue was subsequently 319 
stained with an anti-rabbit IgG antibody conjugated with a fluorescent dye (Alexa 320 
Fluor 594, Life Technologies) prior to immunofluorescent imaging using a 321 
confocal microscope (Zeiss LSM 710).   322 
Mouse quantitative reverse-transcription PCR (RT-qPCR) array. Custom 323 
Taqman® Array Plates (Applied Biosystems) were designed to analyse 3 RNA 324 
samples per plate, with 32 unique assays per sample. Individual RT-qPCR 325 
assays for cellular transcripts (Table S1) were purchased from Applied 326 
Biosystems and were used according to manufacturer’s recommendations.  Total 327 
RNA was extracted from the tip of the left lung of 3 mice per cohort at day 4 p.i. 328 
using an RNA extraction kit (QIAshredder, Qiagen) as instructed by 329 
manufacturer. cDNA was synthesised from 25ng total RNA with random hexamer 330 
primers using a high-capacity RNA-to-DNA reverse transcription kit (Applied 331 
Biosystems) according to manufacturer’s instructions. cDNA was loaded with 332 
Taqman Universal Mastermix (Life Technologies) and run according to 333 
manufacturer’s instructions in a 7500 Q-PCR thermocycler (Applied Biosystems). 334 
Cycle threshold (CT) values were obtained using 7500 Software v2.0.6 (Applied 335 
Biosystems) according to manufacturer’s instructions, and data was exported to 336 
Microsoft Excel for further analysis. Raw CT values were normalised to Gapdh 337 
CT values (dCT) and plotted as 20 - dCT.    338 
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Bioinformatics 339 
All segment 8 sequences were downloaded from GenBank via the Influenza 340 
Virus Resource (48) on 17th October 2014 (31315 sequences).  These data 341 
contained sequences isolated from avian (43%), swine (10%), human (44%) and 342 
other (3%) hosts.  Due to the large number of sequences, the sequences were 343 
aligned in groups, by nucleotides using ClustalW in BioEdit, manually adjusted 344 
for NS1 coding frame with the remaining nucleotides in the NEP coding frame, 345 
then aligned by amino acid using MUSCLE in MEGA6.0.  The major lineages of 346 
influenza A segment 8 (Avian A, Human Seasonal, Classical Swine, H1N1-347 
pdm09, Avian B) were identified in neighbour joining trees - we split the data into 348 
10 random subsamples of approximately 3100 sequences each to make 10 349 
trees, and all the sequences belonging to the Avian lineages were extracted from 350 
the random subsamples, combined and alignments re-checked.  Sequences with 351 
identical isolate names, mixed subtypes, unknown location or year were excluded 352 
to make the Avian A (10914 sequences in total of which 9617 were avian) and 353 
Avian B (2725 sequences in total of which 2717 were avian) data sets (see Table 354 
S2 for the distribution of sequences by all major lineages, hosts, geographic 355 
locations and subtypes).   356 
In order to determine the number of independent introductions from birds to 357 
mammals in the Avian A and B data sets, we created phylogenetic trees using 358 
the neighbour joining method in MEGA6 (with the Tamura-Nei model, gamma 359 
distributed rates among sites and heterogeneous patterns among lineages) in the 360 
first instance.  For the Avian B data set, there were only 8 non-avian sequence in 361 
 o
n
 Septem
ber 7, 2016 by SW
ETS SUBSCRIPTIO
N SERVICE
http://jvi.asm.org/
D
ow
nloaded from
 
 18
total, and by inspection 2 pairs of them were the same or closely related in the 362 
tree, leaving a total of 6 introductions (see Table 2). 363 
The Avian A data set was too large to make one tree for manual inspection, 364 
therefore we subsampled the avian sequences (but not the non-avian 365 
sequences) to a maximum of 3 per year, subtype, host-species type, and 366 
geographic region in order to make a tree of 4886 sequences in total.  In this tree 367 
we manually identified sub-lineages where there were major mammalian 368 
introductions (Old H7N7 equine, H7N7-H3N8 equine-canine, Eurasian swine, 369 
H9N2 human and swine, H7N9 human cases, H10N8 human cases, H3N2 370 
canine, HPAI H5N1), and then marked the other non-avian sequences in FigTree 371 
(Fig. S1). 372 
For all of the 6 Avian B introductions, one representative sequence from each 373 
highlighted Avian A sub-lineage, and all the other Avian A non-avian sequences, 374 
a BLAST search for the 100 closest (or 500 in a minority of cases) other 375 
sequences was performed against GenBank (using custom R scripts). The 376 
returned sequences for each BLAST search were analysed and the host, 377 
subtype, year and geographic region properties for those which were isolated 378 
between 3 and 0 years before the query sequence (or 3 years before and after if 379 
there were not sufficient returns) were extracted and summarised to estimate the 380 
source (domestic or wild birds) of the mammalian introductions.  We also used an 381 
alternative means to estimate the source of the mammalian introductions - a 382 
neighbour joining tree from the returned sequences was constructed (per query 383 
sequence), and a simple discrete trait model for host species (states: domestic-384 
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galliformes, domestic-anseriformes, wild-anseriformes, wild-other, non-avian) 385 
assuming equal rates using R package APE was fitted (49) to enable the 386 
inference of the avian host species of the ancestor of the mammalian sequence 387 
(or sequences).  Finally all the small trees generated from the BLAST searches 388 
were manually inspected, and searches performed in the literature for information 389 
about the query isolate.  Results from non-independent introduction isolates were 390 
removed, and a final list of independent mammalian introductions from avian 391 
sources was compiled by manual curation (Tables 2 and 3, and Table S3). 392 
393 
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Results 394 
A- and B- allele avian NS segment reassortants replicate efficiently in 395 
mammalian cells. As a first test of whether introduction of an avian virus-derived 396 
A- or a B- allele segment 8 into a mammalian adapted virus introduced a fitness 397 
penalty in cultured mammalian cells, a panel of segment 8 reassortant viruses 398 
was generated on the background of PR8. The NS segments were taken from a 399 
variety of North American LPAI strains collected between 1986 and 2005 (Table 400 
1) and were introduced into PR8 using a well-established reverse genetics 401 
system (34). The NS1 proteins of these viruses were at least 99% homologous 402 
within their respective A- or B-allele group, and typically shared only 71% amino 403 
acid homology between groups (see Fig. S2), consistent with previous reports 404 
(23, 24). All viruses rescued readily. To assess viral protein expression during 405 
infection, MDCK cells were infected at an MOI of 3 and cell lysates were taken at 406 
8 h p.i. and subjected to SDS-PAGE and western blotting for viral NP, M1, M2, 407 
and NS1 proteins. All viruses produced comparable amounts of NP, M1 and with 408 
some minor fluctuations, M2 (Fig. 1). NS1 from all viruses was also readily 409 
detected, with anti-PR8 NS1 serum V29 reacting with PR8 and the A-allele 410 
polypeptides, and the B-allele serum A2 reacting with all avian NS1s. Avian 411 
NEPs could not be reliably detected by western blotting with the available 412 
antisera (data not shown), but immunoprecipitation of radiolabelled cell lysates 413 
with the same serum provided unambiguous evidence of NEP expression by all 414 
viruses (Fig. 1). Thus, introduction of an LPAI strain NS segment, from either the 415 
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A- or B- lineage, did not obviously attenuate viral protein expression in MDCK 416 
cells.    417 
To assess the replicative capabilities of the reassortant viruses in 418 
mammalian cells, MDCK cells were infected at an MOI of 0.001 and virus in the 419 
supernatant was titrated by plaque assay at 48 h p.i. All viruses replicated to 420 
greater than 108 PFU/ml, and there were no statistically significant differences 421 
(assessed by an unpaired t-test) between A- and B- allele reassortant virus titres 422 
(Fig. 2A). Additionally, plaque phenotypes in MDCK cells were indistinguishable 423 
between the viruses (data not shown). We next investigated virus growth kinetics; 424 
MDCK cells were infected at an MOI of 0.001 with either WT PR8 or consensus 425 
A- and B- allele NS segment reassortants (O175A and O265B, respectively), and 426 
virus in the supernatant was titrated across a time course. All viruses replicated 427 
with similar growth kinetics, producing a peak viral titre of approximately 108 428 
PFU/ml at 24 h p.i. (Fig. 2B). To assess virus replication in continuous human 429 
cells, A549 cells were infected at an MOI of 0.001 and virus in the supernatant 430 
was assessed at 48 h p.i.. All viruses replicated to similar end-point titres of 431 
approximately 107 PFU/ml (Fig. 2C). When the kinetics of replication in A549 432 
cells of consensus reassortant viruses were examined, WT PR8 and O265B 433 
were essentially indistinguishable, while O175A replication slowed after 24h to 434 
reach an end-point titre that was approximately one order of magnitude lower. 435 
(Fig. 2D). Similarly, the whole panel of segment 8 reassortant viruses replicated 436 
to similar viral titres as WT PR8 following multi-cycle infection of human epithelial 437 
colorectal adenocarcinoma cells (data not shown). To assess replication in 438 
 o
n
 Septem
ber 7, 2016 by SW
ETS SUBSCRIPTIO
N SERVICE
http://jvi.asm.org/
D
ow
nloaded from
 
 22
primary human cells, CD14+ monocyte-derived macrophages (MDMs) were 439 
infected at an MOI of 3 and virus in the supernatant was titrated at 24 h p.i. All 440 
viruses replicated to similar titres of greater than 106 PFU/ml (Fig. 2E).  441 
Therefore, introduction of avian NS segments of both the A- and B- lineage does 442 
not necessarily attenuate PR8 virus replication in primary or continuous human 443 
cell lines.  444 
Since we had failed to observe any significant attenuation of virus 445 
replication using the North American LPAI NS segment reassortant viruses, we 446 
generated further reassortant viruses using NS genes that spanned a wider date 447 
and geographical range and that had either been studied previously (18, 27), or 448 
were deemed to be of particular interest, such as the Jilin89 NS segment or the 449 
human isolate NY107B (See Table 1). Reassortant viruses were generated on 450 
the PR8 background as before and multicycle replication assessed in MDCK 451 
cells. Again, all viruses replicated to titres approaching 108 PFU/ml with no 452 
obvious difference between A and B alleles (Fig. 2F).  453 
To test if these results were specific to the laboratory-adapted PR8 454 
backbone, we generated NS segment reassortant viruses on the backgrounds of 455 
the human pandemic H1N1 strain Cal7 or H3N2 strain Udorn72 and assessed 456 
multicycle growth in mammalian cells. MDCK-SIAT cells were infected at an MOI 457 
of 0.01 with the Cal7 reassortant viruses and infectious progeny virus was titrated 458 
at indicated time-points by plaque assay. WT Cal7 and the Cal7/PR8 reassortant 459 
viruses replicated with similar kinetics, with peak titres of 106 PFU/ml at 72 h p.i. 460 
(Fig. 2G). In comparison, the avian segment 8 reassortant viruses displayed 461 
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delayed growth kinetics and gave ~ 10-fold lower peak titres at 72 h p.i.. 462 
However, replication kinetics between the Cal7-based A- and B-allele reassortant 463 
viruses were indistinguishable, providing no evidence for a B-allele-specific 464 
effect. The Udorn72 viruses all replicated in MDCK cells with similar growth 465 
kinetics, barring minor differences at 24 h p.i., giving peak titres of approximately 466 
107 PFU/ml (Fig. 2H). Overall therefore, introduction of either A- or B-allele avian 467 
NS segments into human H1N1 and H3N2 strains does not generally attenuate 468 
replication in mammalian cells in vitro. This suggests that the NS1 and NEP 469 
proteins of both the avian A- and B- allele lineages are able to carry out essential 470 
functions efficiently in mammalian cells during infection. 471 
A B-allele NS1 protein is efficient at controlling the mammalian innate 472 
immune response in vitro. Since it has been suggested that NS1 proteins 473 
belonging to the B-allele lineage cannot efficiently suppress a mammalian host 474 
innate immune response (26-29, 50), we investigated the ability of the consensus 475 
PR8 segment 8 reassortant viruses to circumvent and control the host cell type I 476 
IFN response. Firstly, human A549 cells were pre-conditioned for 24 h with 477 
varying concentrations of human IFN-β prior to infection at an MOI of 0.01. The 478 
endpoint titres of these multicycle replication reactions were then determined by 479 
plaque assay, while cell lysates were subjected to SDS-PAGE and western 480 
blotting for Mx-1, viral NP and tubulin. All viruses displayed a similar dose-481 
response to exogenous IFN-β treatment, being largely insensitive to treatment 482 
with less than 10 U/ml but increasingly inhibited by larger doses (Fig. 3A).  The 483 
IC90 values were very similar between PR8, O175A and O265B (28.5 U/ml, 29.6 484 
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U/ml and 33.5 U/ml respectively). Increased concentrations of IFN-β pre-485 
treatment correlated with increased levels of the interferon sensitive Mx-1 protein 486 
and decreased levels of viral NP (Fig. 3B). Therefore, both A- and B- allele NS 487 
segment reassortant viruses are equally as effective at replicating in the 488 
presence of prior induction of the host innate immune response in mammalian 489 
cells as a mammalian-adapted virus. Next, we investigated the levels of type I 490 
IFN secreted from A549 cells in response to virus infection. A549 cells were 491 
infected for 24 h at an MOI of 3, 0.3 or 0.03, with WT and reassortant PR8 492 
viruses, or as a positive control, with a PR8 NS1 mutant (R38K41A) known to be 493 
defective in its control of type I IFN expression (51, 52). The supernatants were 494 
then u.v.-treated to inactivate virus and the amount of type I IFN estimated by 495 
bio-assay on HEK Blue cells (53) in comparison to a standard curve generated 496 
with known amounts of IFN-β. Cells infected at high or low multiplicities with the 497 
R38K41A virus produced approximately 100 U/ml type I IFN (Fig. 3C). In 498 
contrast, WT PR8, O175A, and O265B infection (at any MOI tested) failed to 499 
induce levels of type I interferon significantly above the background of the assay 500 
(approximately 6.75 U/ml IFN-β). We then assessed the full panel of PR8- and 501 
Udorn72-based reassortant viruses at an MOI of 3, and in no case was type I IFN 502 
detected in the supernatant of infected A549 cells above background levels (Figs 503 
3D & 3E). Thus, LPAI A- and B-allele NS1 proteins are able to effectively 504 
suppress type I IFN expression during infection to a level below that estimated to 505 
be inhibitory to virus replication, based on dose-response curves of human IFN-β 506 
(Fig. 3A). Additionally, we tested various A- and B- allele NS1 proteins in their 507 
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ability to block the activation of the IFN-β promoter following stimulation with 508 
poly(IC), and found that all avian NS1s tested were sufficient in blocking this 509 
activation (data not shown). These data suggest that B-allele NS1 proteins are in 510 
fact able to successfully supress the overall mammalian interferon response in 511 
vitro, contrary to previous reports (26-29).  512 
We next looked at cytokine and chemokine secretion from infected primary 513 
human macrophages, since macrophages are important mediators of the host 514 
immune response to influenza virus infection (54, 55). Human CD14+ MDMs 515 
were infected at an MOI of 1 and the supernatant harvested after 24 h. 516 
Successful infection was demonstrated by western blotting for viral NP (data not 517 
shown). The levels of various secreted cytokines and chemokines following 518 
infection with PR8, O175A or O265B were then quantified using an antibody 519 
capture array. Relative to a mock-infected sample, infection led to up-regulation 520 
of several cytokines and chemokines, with macrophage inhibitory factor (MIF), 521 
tumour necrosis factor alpha (TNF-α), chemokine (C-C) motif ligand 3 (CCL3), 522 
chemokine (C-C) motif ligand 5 (CCL5), C-X-C motif chemokine 10 (CXCL10), 523 
interleukin 16 (IL-16), interleukin 1 receptor antagonist (IL-1ra), interleukin 1 beta 524 
(IL-1β) and C-X-C motif chemokine 12 (CXCL12) all up-regulated at least 2-fold 525 
following infection with all three viruses (Fig. 4A). The O175A and O265B 526 
reassortant viruses produced similar secretome profiles, which were both lower in 527 
pro-inflammatory mediators TNF-α, CCL3 and CCL5 than that resulting from WT 528 
PR8 infection (Fig. 4A). Thus, there is no evidence to suggest that there is an 529 
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elevated macrophage response to viruses with a B-allele NS segment in human 530 
macrophages in vitro in comparison to an A-allele counterpart.  531 
To assess the global host cell response to infection with NS segment 532 
reassortant viruses, we measured changes in host cell proteins over a full time-533 
course of infection with each virus in A549 cells using new multiplexed tandem 534 
mass tag (TMT)-based mass spectrometry (45). This technology enables direct 535 
comparison of temporal infection with each virus within a single experiment. Cells 536 
were infected at an MOI of 5 and cell lysates were taken at 8 h, 16 h, and 24 h 537 
p.i.. Immunofluorescent analysis of NP expression confirmed a mean infection 538 
rate of 95% across all virus-infected samples and time-points (data not shown). 539 
6862 unique proteins were quantified, which were clustered according to fold 540 
change in expression relative to the uninfected samples (Fig. 4B). Only a minority 541 
of cellular proteins changed abundance significantly in response to infection, with 542 
the majority of these decreasing (see Table S4). However, the IFN-inducible 543 
factors Mx-1, interferon-induced protein with tetratricopeptide repeats 2 (IFIT2), 544 
2'-5'-oligoadenylate synthetase-like protein (OASL), interferon-induced protein 545 
with tetratricopeptide repeats 3 (IFIT3), interferon-induced protein with 546 
tetratricopeptide repeats 1 (IFIT1) and interferon induced with helicase C domain 547 
1 (IFIH1) formed one example of a sub-cluster of highly upregulated host factors 548 
in the PR8-infected samples (Fig. 4C). These genes were also induced in 549 
O175A- and O265B-infected cells, but generally to a lesser extent (Fig. 4C). 550 
Thus, WT PR8 is actually a greater inducer of host antiviral responses than either 551 
A- or B-allele avian NS segment reassortant viruses, suggesting that neither A- 552 
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or B-allele NS1 proteins from avian viruses are deficient in controlling the 553 
mammalian innate immune response.  554 
Relative fitness of A- and B-allele segments. To assess more subtle 555 
differences in replicative fitness between NS segment reassortant viruses, we 556 
performed mixed infections and then estimated the proportion of progeny virus 557 
that carried A- or B-allele NS segments. Initially, we tested whether, over the 558 
course of multiple rounds of replication in mammalian cells, the A-allele NS 559 
segment had a selective advantage in mammalian cells that would let it out-560 
compete the B-allele. MDCK cells were infected with both O175A and O265B at 561 
an MOI of 0.001 each, and at 48 h p.i. clonal populations of progeny virus were 562 
isolated by plaque purification. Allele-specific RT-PCR reactions were then 563 
performed to identify the source of segment 8.  Control reactions showed that 564 
strong signal was only obtained in PCR reactions containing homologous viral 565 
RNA and primers (Fig. 5A, lanes 1-4, 9-14), such that individual plaque picks 566 
from co-infections could be unambiguously scored (see lanes 5-8 for examples). 567 
When 25 plaques from the co-infection were scored by this method, the B-allele 568 
accounted for over 60% of the progeny (Fig. 5B). The output virus population was 569 
passaged twice further at MOI 0.001, and 25 plaques were assayed at each 570 
passage. O265B maintained an advantage over O175A through these multiple 571 
rounds of replication, forming 72% of plaques by passage 3 (Fig. 5B). When 572 
either avian segment 8 was similarly competed against the wild-type PR8 573 
segment 8, PR8 heavily out-competed both O175A (96% to 4%) and O265B 574 
(88% to 12%) by the end of the third passage (Fig. 5B). Thus, there was no 575 
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evidence of even a small replicative fitness penalty for O265B compared to 576 
O175A (if anything, the B-allele appeared to “win”), but both avian segments 577 
were less fit than the PR8 gene.  578 
Previously, we suggested that differences in the terminal packaging signal 579 
regions of segment 8 might restrict the incorporation of the B-allele into an A-580 
allele background (56). To test this, we performed high multiplicity co-infections, 581 
such that the majority of infected cells would be expected to contain both 582 
segment 8s; the proportion of progeny virions containing an individual NS gene 583 
would therefore reflect the facility with which it was packaged into the PR8 virus 584 
background. MDCK cells were infected at an MOI of 3 per virus and at 16h p.i. 585 
progeny virus was collected and individual plaques were assayed as before. 586 
When O265B was competed against O175A in three independent experiments, 587 
allele B-containing plaques out-numbered O175A by approximately 3:1 (Fig. 5C). 588 
RT-qPCR analysis of intracellular segment 8 levels showed a 2.5:1 ratio in favour 589 
of the B-allele segment (data not shown), suggesting that the packaging 590 
efficiencies of O175A and O265B NS vRNA were similar. Similarly, when either 591 
of the avian segment 8s were competed against the PR8 segment in high 592 
multiplicity co-infections, B-allele plaques were nearly equal in proportion with 593 
WT PR8 (52% to 48%), while WT PR8 modestly out-competed O175A (69% to 594 
31%) (Fig.5C). Therefore, contrary to our original hypothesis, there is no 595 
evidence for selective packaging of an A-allele segment into PR8 virions when 596 
both A and B segments are present in an infected cell.  597 
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We next looked at co-infection in vivo. 5 BALB/c mice were intranasally 598 
infected with 250PFU each of O175A and O265B. At day 6 p.i., the left lung of 599 
each mouse was harvested. 12 plaques were assayed from each lung 600 
homogenate and the proportion of O175A and O265B in the lung estimated. In 601 
one sample, viruses bearing the O175A segment 8 predominated, but in all other 602 
samples O265B provided the majority or even all isolates (Fig. 5D). On average, 603 
O265B out-competed O175A by two to one (66% to 34%) in vivo. Thus, there is 604 
no obvious selection advantage for an avian A-allele NS segment over a B-allele 605 
counterpart either in vitro or in vivo. 606 
A B-allele reassortant virus is more pathogenic than an avian A-allele 607 
counterpart in vivo.  We assessed the ability of the consensus segment 8 608 
reassortant viruses to replicate and cause disease in vivo. Groups of 5 BALB/c 609 
mice were challenged with 500PFU of WT PR8, O175A, O265B or mock-infected 610 
with media. Mock-infected mice maintained a healthy body weight over 6 days 611 
whereas all infected mice lost weight from day three onwards (Fig. 6A). By this 612 
criterion, WT PR8 was the most virulent strain, causing the greatest weight-loss, 613 
whereas both avian segment 8s apparently led to attenuated disease. 614 
Surprisingly however, O265B induced more weight-loss than O175A. Mean 615 
weight-loss at day 4 p.i. was 16.9%, 3.1% and 8.4% starting body-weight for 616 
PR8-, O175A-, and O265B- infected mice respectively (n=10). By day 6 p.i., PR8, 617 
O175A and O265B induced a mean weight-loss of 25.8%, 8.2% and 19.3%, 618 
respectively (n = 5). All groups were significantly different from one another from 619 
day 3 p.i. onwards, with the exception of O175A-infected mice at day 5 p.i. which 620 
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were not significantly different from mock-infected mice (unpaired t-test, Fig. 6A). 621 
The same outcome of PR8 causing the greatest weight-loss and O175A the least 622 
was obtained in independent replicate experiments, including one with a lower 623 
inoculation dose of 100 PFU/animal where WT PR8 and the 0265B reassortant 624 
gave mean nadir weights of 82.0% (+/- 1.0% SD) and 91.7% (+/- 2.1% SD) on 625 
day 7 respectively before recovery, while 0175A-infected animals gained weight 626 
throughout the experiment (data not shown). Thus, introduction of avian virus NS 627 
segments into PR8 attenuated disease in vivo, but this attenuation was the least 628 
with a B-allele segment.  629 
To further assess replication characteristics in vivo, the lungs of infected 630 
mice were harvested at days 2 and 6 post-infection, homogenised and virus titres 631 
measured.  At day 2 p.i., all three viruses had replicated to titres around 1 x106 632 
PFU/ml of homogenate and while the average WT PR8 titre was approximately 633 
3-fold greater than both O175A and O265B, the differences were not statistically 634 
significant (unpaired t-test) (Fig. 6B). At day 6, the titres of all three viruses had 635 
dropped, but to significantly different extents, with WT PR8 giving the highest 636 
titres and O175A the lowest (unpaired t-test). Thus the source of segment 8 had 637 
relatively little effect on virus replication at early times post infection, but 638 
significantly affected virus clearance. As before however, the B-allele was less 639 
attenuating than the avian virus-derived A-allele. When lung sections from days 640 
2, 4 and 6 p.i. were examined by immunofluorescent staining for viral NP, in all 641 
cases, infected cells were found most frequently in airway epithelia, but also in 642 
interstitial tissue (Fig. 6C). In general, the number of positive cells correlated with 643 
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the titres of infectious virus, with PR8-infected cells appearing to be more 644 
widespread than O265B and O175A (data not shown), but overall, the source of 645 
segment 8 did not noticeably affect virus tropism. 646 
To assess and compare the severity of pathology caused by each of the 647 
viruses, the lungs of infected mice at day 6 p.i. were fixed, processed, sectioned, 648 
stained with hematoxylin and eosin and then examined to assess and score the 649 
histopathological changes present. All three viruses caused lesions consistent 650 
with IAV infection, characterised by mild to marked, subacute, multifocal, 651 
nonsuppurative, bronchointerstitial pneumonia with necrosis and fibrin 652 
accumulation. Degeneration and necrosis of epithelial cells lining the airways, 653 
accompanied by peribronchiolar, peribronchial, and perivascular inflammation, 654 
was a consistent feature (Fig. 7A). The inflammatory infiltrate was predominantly 655 
lymphocytic and histiocytic with variable numbers of neutrophils. Scoring of the 656 
severity and extent of the changes revealed no difference in the pathology 657 
present in mice infected with the PR8, O265B or O175A viruses (Fig. 7B).  658 
To examine the antiviral response in vivo following infection with the 659 
reassortant viruses, we first quantified the expression of an array of antiviral 660 
genes (selected to represent cytokines and chemokines, interferons and 661 
interferon sensitive genes – see Table S1) in the lungs of infected mice at day 4 662 
p.i. using qRT-PCR. The expression of most genes was significantly up-regulated 663 
in infected mice in comparison to mock-infected controls (Fig. 7C). In general, 664 
WT PR8 induced more antiviral gene expression than either NS segment 665 
reassortant virus, while O265B tended to be higher than O175A.  However, the 666 
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majority of differences were not statistically significant, with the only exceptions 667 
being Csf1 and Csf3 which were both significantly up-regulated by WT PR8 in 668 
comparison to O175A infected mice (n = 3, p<0.05, unpaired t-test). There were 669 
no instances of gene expression being significantly different between O175A- 670 
and O265B- infected lungs. To check for the possibility of biologically significant 671 
post-transcriptional regulation, we next created proteome profiles of infected 672 
mouse lung (using pooled lung homogenates from groups of 5 mice) at day 4 p.i. 673 
for various cytokines and chemokines using an antibody capture array. WT PR8 674 
infection induced higher levels of pro-inflammatory cytokines such as TNF-α, 675 
CXCL12, and interleukin 6 (IL-6) than the segment 8 reassortant viruses, while 676 
the profiles of O175A and O265B were more similar to each other than PR8 (Fig. 677 
7D). Thus, in vivo as well as in vitro, WT PR8 was the strongest inducer of the 678 
host antiviral response, but in this background, an avian B-allele segment 8 679 
caused greater disease than an A-allele counterpart and allowed prolonged virus 680 
persistence in the host.  681 
The B-allele NS gene of influenza A virus reassorts into mammalian 682 
adapted viruses at similar rates as the A-allele. 683 
The behaviour of our reassortant viruses failed to provide evidence that the B-684 
allele NS segment is especially maladapted to a mammalian host. However, this 685 
hypothesis is founded on the presumption that B-allele segment 8s are rarely 686 
found in viruses isolated from mammals, a view dating back over 25 years, when 687 
there were far fewer IAV sequences available. We therefore decided to revisit the 688 
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question of how often avian virus-derived segment 8 jump into mammalian hosts, 689 
using the much larger number of virus sequences now available.  690 
All NS segment sequences on GenBank were downloaded and grouped 691 
into A- or B-alleles (see Methods and Table S2). These sequences were 692 
phylogenetically clustered to identify the major lineages of influenza A segment 8 693 
(Fig. 8), including several obvious large clades of isolates from mammalian hosts 694 
that had likely acquired an NS segment from an ancestral avian IAV (e.g. human 695 
seasonal/classical swine/pdm2009, Eurasian swine). To identify other avian to 696 
mammalian transmission events, the trees were examined for phylogenetically 697 
incongruent examples of mammalian isolates within otherwise avian-derived 698 
branches. (Figs. 8, 9, S1 and Table S3). In some instances, these apparently 699 
represented single transmission events (accepting the limitations of sample bias), 700 
whereas others clearly reflected the successful introduction of an avian segment 701 
into a mammalian population. Since we wanted to estimate the numbers of 702 
independent introductions of an avian A- or B-allele NS segment into mammals, 703 
the latter class was still treated as one event. This approach identified 6 704 
occasions on which a B-allele NS segment had demonstrably transferred to a 705 
mammalian host (Fig. 9; Table 2), and 32 occasions for A-allele NS segments 706 
(Fig S1; Table 3). Thus A-allele host jumps from Aves to Mammalia outnumber 707 
B-allele jumps by over five to one. However, A- and B-allele segments may not 708 
be equally distributed amongst the source population, as the total number of 709 
avian A-allele sequences available in GenBank outnumber B-allele sequences by 710 
approximately 3.5 to 1 (see Tables 4 and S2). Using Fisher tests, we found that 711 
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the number of mammalian introductions per avian isolate was not significantly 712 
different between A and B alleles (A: 32 from 9617 and B: 6 from 2717, p-value = 713 
0.436). We further considered if there might be a difference in the detected 714 
number of introductions depending upon whether the avian source was wild or 715 
domestic birds, since the contact rate between the often sampled ‘domestic 716 
mammals’ (e.g. humans and swine) and domestic birds could be very different to 717 
that from wild birds. Indeed, a larger proportion of the B-allele sequences were 718 
sampled from wild birds, and from North America, than the avian A-allele genes 719 
(Fig. 10). However, there was also no significant difference between A- and B-720 
alleles considering likely domestic bird to mammal (p-value = 0.756) or wild bird 721 
to mammal (p-value = 0.578) introductions (Table 4). Thus overall, the currently 722 
available surveillance/sequencing data do not support the hypothesis that the B-723 
allele NS segment is specifically restricted in mammalian hosts but instead 724 
suggest that the introduction of any avian segment 8 into mammals is a relatively 725 
rare event. 726 
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Discussion 727 
To date, there has been conflicting evidence regarding the fitness of IAV 728 
strains containing B-allele of the NS segment 8 in mammalian hosts; from 729 
early evidence for restriction in mammals through to more recent studies that 730 
have begun to question this (18, 26-30, 57). Here, we find no major fitness 731 
penalty incurred in vitro or in vivo by H1N1 and H3N2 mammalian-adapted 732 
influenza viruses forcibly reassorted with B-allele NS segments. We tested 733 
three mammalian-adapted “backbone” viruses and a panel of A- and B-allele 734 
NS segments from a variety of isolates, predominantly LPAI strains from 735 
North America (Table 1); all viruses replicated to high peak titres in a variety 736 
of mammalian cell lines, and achieved normal viral protein expression (Figs 1 737 
& 2). NEP is essential for virus replication (58), while deletion of NS1 severely 738 
attenuates virus replication in cells (59). Thus, despite their divergent avian 739 
virus-origin, the B-allele NS1 and NEP proteins are both able to effectively 740 
carry out essential support functions in mammalian cells in vitro. Indeed, in 741 
competition assays in vitro and in vivo, the B-allele reassortant consistently 742 
outperformed its avian A-allele counterpart (Fig. 5). 743 
There is evidence, largely based on transfection-based reporter assays 744 
examining the function of individual cellular promoters, that B-allele NS1 745 
proteins are less effective at suppressing the activation of specific innate 746 
immunity pathways in mammalian cells than A-allele counterparts (26-29, 50). 747 
Consistent with these data, we also found significant differences in the ability 748 
of certain avian NS1s to antagonise RNA Pol II-mediated gene expression 749 
from transfected plasmids with SV40 or ISRE, but not the IFN-ß promoters 750 
(data not shown). However, in the context of virus infection, both A-allele and 751 
 o
n
 Septem
ber 7, 2016 by SW
ETS SUBSCRIPTIO
N SERVICE
http://jvi.asm.org/
D
ow
nloaded from
 
 36
B-allele H1N1 and H3N2 reassortant viruses controlled the secretion of active 752 
type I IFN from infected human lung cells to below an inhibitory level (Figs 3C, 753 
3D and 3E). These observations are complemented by a previous report 754 
showing that avian NS1 proteins, from both A- and B-allele lineages, were 755 
able to antagonise type I IFN induction in human cells in infection-based 756 
reporter studies (60). Additionally, O175A and O265B displayed no obvious 757 
hypersensitivity to IFN-β pre-treatment in human lung cells (Fig. 3A) and did 758 
not stimulate a large cytokine/chemokine response in primary human 759 
macrophages (Fig. 4A). In fact, both avian segment reassortants induced less 760 
of an antiviral response than wild-type PR8 virus in vitro in human lung cells 761 
(Figs. 4B and 4C) and in vivo in mouse lungs (Figs. 7C and 7D). Thus both A- 762 
and B-allele NS1 proteins from LPAI avian strains can effectively control the 763 
overall mammalian innate immune response and circumvent an induced 764 
antiviral state, even if perhaps the suite of mechanisms deployed show some 765 
differences.  766 
We also considered whether penetration of the B-allele segment into 767 
mammalian strains of virus might be restricted at the level of reassortment. 768 
IAV is known to package each segment specifically, with RNA packaging 769 
signals directing the process (56, 61). The packaging signals for segment 8 770 
partially overlap variable regions between the alleles and we previously 771 
hypothesised that this might hinder free reassortment of the avian B segment 772 
into an otherwise mammalian-adapted virus background (56, 62). However, 773 
the outcome of high multiplicity co-infections of the A- and B-allele viruses, in 774 
which every cell would be expected to contain both segment 8s that would 775 
then compete for incorporation into the A-allele PR8 background, did not 776 
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support the hypothesis, with the B-allele outperforming the avian A-allele and 777 
“drawing” against the PR8 segment (Fig. 5C).  This outcome is consistent with 778 
other work indicating a surprising amount of plasticity in the segment 8 779 
packaging signal (63). Overall, the data therefore do not suggest that a B-780 
allele NS vRNA segment is less likely to be introduced into an IAV circulating 781 
in mammalian hosts by genetic reassortment in nature.  782 
Having failed to find any convincing evidence for a replicative penalty 783 
for the B-allele NS segment in vitro or in vivo, we began to question the 784 
validity of the long-held view that the B-allele is restricted in mammals. There 785 
is evidence to suggest that the B-allele NS segment of IAV attenuates a 786 
human IAV in vivo. Treanor et al. made human H3N2 NS reassortant viruses 787 
and noted an attenuation in virus replication in the nasopharynx of squirrel 788 
monkeys and a reduced shedding duration of a B-allele reassortant in 789 
comparison to an A-allele counterpart (18). However, peak virus titre of the B-790 
allele reassortant virus in the trachea was not significantly reduced, 791 
suggesting that the virus could replicate effectively in this part of the 792 
respiratory tract. Here, we challenged BALB/c mice with PR8-based NS 793 
reassortant viruses and found that PR8, O175A and O265B were all able to 794 
cause clinical disease and replicate in vivo. Wild-type PR8 caused the most 795 
severe disease in terms of weight-loss (Fig. 6A) and this could be due to a 796 
greater induction of cytokines, chemokines, and interferon-sensitive genes in 797 
the lungs of infected mice (Figs. 7C and 7D), or due to prolonged viral 798 
persistence in the lung as judged by viral titres at day 6 p.i. (Fig. 6B). It is not 799 
surprising that wild-type PR8 caused the greatest disease, since this strain is 800 
already mouse-adapted (64) (our PR8 clone has a 50% mouse-lethal dose 801 
 o
n
 Septem
ber 7, 2016 by SW
ETS SUBSCRIPTIO
N SERVICE
http://jvi.asm.org/
D
ow
nloaded from
 
 38
(MLD50) of ~ 100 PFU) and it is known that the NS1 and NEP genes incur 802 
adaptive mutations following passaging in mice (17). Nevertheless, both avian 803 
NS reassortants caused overt disease, including indistinguishable levels of 804 
classical IAV-induced lung histopathology. O265B induced more severe 805 
weight-loss than O175A; however the cytokine, chemokine, and ISG profiles 806 
in infected mouse lung were not significantly different between the two. PR8, 807 
O175A and O265B had similar peak viral titres at day 2 p.i., and the rate of 808 
clearance was O175A>O265B>PR8, which was inversely correlated with 809 
severity of weight-loss (Fig. 6B). Thus in this mammalian infection model, a B-810 
allele NS segment is compatible with high levels of virus replication and 811 
pathogenicity. Our data are not alone in finding that a B-allele segment is 812 
compatible with virulence in mice; a recent study found that insertion of a B-813 
allele NS segment into a PR8 variant with a markedly higher MLD50 of ~ 105 814 
PFU did not further attenuate the virus (65), while others found that insertion 815 
of a B-allele NS segment into a previously avirulent laboratory-adapted HPAI 816 
strain of fowl plague virus actually caused a dramatic increase in 817 
pathogenicity (30). Thus overall, B-allele containing viruses seem entirely 818 
capable of supporting substantial levels of virus replication and disease in 819 
laboratory animal models.  820 
Twenty years ago, the other main strand of evidence for host-restriction 821 
of B-allele NS genes was the paucity of mammalian-derived isolates (23, 24, 822 
66). However, the number of sequenced IAV isolates has since risen 823 
exponentially and following the first report of a mammalian (equine) B-allele-824 
containing virus (25), there have been a number of other instances noted, 825 
from swine and other species, including man (Table 2). It was therefore 826 
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important to reappraise the question of whether the introduction of avian virus-827 
derived NS segments into mammalian hosts is truly biased against one allele 828 
or another.   We identified ~ 12000 unique avian-derived NS sequences in 829 
GenBank, of which over three quarters were A-allele segments.  A parallel 830 
analysis of mammalian-derived NS sequences for phylogenetically 831 
incongruent sequences that represented introduction of an avian virus gene 832 
into a mammalian host, as well as considering well-established histories of 833 
IAV evolution (most notably the 1918 NS segment, which founded the 834 
widespread classical swine, human H1N1, H2N2, H3N2 and pdm2009 835 
lineages from a single event) identified 32 separate instances of an avian A-836 
allele and 6 of a B-allele jumping into mammals. This gives ‘rates’ of 32/9617 837 
and 6/2717 or 0.0033 and 0.0022 respectively for mammalian incursions per 838 
unique avian isolate (Table 4). These estimates are potentially affected by 839 
biases inherent to the data, most especially sampling bias. The B-allele might 840 
truly be less prevalent in the avian population, or it might preferentially infect 841 
bird species that are less frequently sampled (Fig. 10). For example, Adams 842 
et al reported that a B-allele reassortant was less competent at replicating in 843 
chicken and turkey cells in comparison to an A-allele equivalent, but was 844 
more fit in duck cells (67). However, surveillance data show that B-allele 845 
influenza viruses can infect poultry (Fig. 10), have the ability to persist (68) 846 
and to be highly pathogenic (69). Conversely, the mammalian isolates are 847 
undoubtedly biased in the species that are sampled. We also accept that the 848 
boundary of an “independent” introduction can be defined in different ways. 849 
For instance, whilst forward transmission of the original avian-derived equine 850 
H3N8 virus to dogs clearly does not count as two independent introductions 851 
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(going from bird -> mammal -> mammal), how does one define the repeated 852 
zoonotic infection of a widespread avian virus such as H5N1 into man? We 853 
chose to define this as two major introduction events: the original 1997 event, 854 
and the subsequent re-introduction from domestic poultry in 2003, since the 855 
multiple human infections are monophyletic in each case. Nevertheless, taken 856 
on face value, our analysis of the currently available sequences do not 857 
support the hypothesis of the B-allele being specifically restricted to avian 858 
hosts. Instead, it seems that the transfer of any avian segment 8 to mammals 859 
is a relatively rare event.  860 
Successful cross-species transmission does not necessarily equate 861 
with establishment in the new host. Further inspection of the Aves -> 862 
Mammalia transmission events suggests a divide into isolated events with 863 
little or no documented onward transmission in the mammalian host and those 864 
where the virus containing the avian segment 8 has persisted, at least for a 865 
period. The available information suggests that 3 of 6 B-allele viruses 866 
transmitted between mammals, most notably the 1989 H3N8 outbreak in 867 
horses (Table 2, (25)). For the A-allele viruses, perhaps 19 out of 32 seem to 868 
have been transmissible, with half a dozen or more events leading to long 869 
term establishment of the virus in a new host.  Statistically, these data do not 870 
support the hypothesis that the transmissibility of IAV with allele A or B NS 871 
segments are different (Table 4). However the number of observed 872 
introductions is small and there may be confounding effects from other 873 
segments.  Further work would be necessary to test the possibility that 874 
transmission between mammalian hosts is attenuated due to the B-allele NS 875 
segment. Overall, we conclude that it is misleading to simply consider the B-876 
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allele of the NS segment as being particularly restricted to avian host species; 877 
a factor to be borne in mind when risk assessing the zoonotic/epizootic 878 
potential of avian influenza strains (31). 879 
880 
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Table 1. Virus strains.  1277 
Virus 
Name 
Strain from which NS segment isolated Allele Accession 
number (NS) 
PR8 A/Puerto Rico/8/1934 (H1N1) A EF467817.1 
Cal7 A/California/7/2009 (H1N1) A Unpublished 
Udorn72 A/Udorn/72 (H3N2) A CY009640.1 
O175Aa A/green-winged teal/Ohio/175/1986 (H2N1) A CY018881.1 
O173A A/mallard/Ohio/173/1990 (H11N9) A CY021665.1 
O340A A/green-winged teal/Ohio/340/1987 (H11N9) A CY021873.1 
M1124A A/mallard/Maryland/1124/2005 (H11N9) A CY021473.1 
O265Ba A/Mallard/Ohio/265/1987 (H1N9) B CY017279.1 
O430B A/green-winged teal/Ohio/430/1987 (H1N1) B CY011044.1 
O264B A/mallard/Ohio/264/1986 (H3N8) B CY016399.1 
O339B A/pintail/Ohio/339/1987 (H3N8) B CY019201.1 
O668B A/mallard/Ohio/668/2002 (H4N6) B CY020793.1 
O671B A/mallard/Ohio/671/2002 (H4N6) B CY020801.1 
O35B A/northern shoveler/Ohio/35/1986 (H3N8) B CY020937.1 
O246B A/bufflehead/Ohio/246/1986 (H11N2) B CY017079.1 
Alb88Bb A/mallard/Alberta/88/1976 (H6N8) B M25373.1 
NY6750Ac A/mallard/New York/6750/1978 (H2N2) A M25376.1 
Sw418Bd A/mallard/Sweden/S90418/2005 (H6N8) B EU518722 
NY107Be A/New York/107/2003 (H7N8) B EU587374.2 
J89B A/equine/Jilin/1/1989 (H3N8) B M65020.1 
a Used as representative “consensus” A and B genes for specific experiments. 1278 
b1-15 & 855-890 from ALB/221/1978(H7N2) (CY005035.1). G242A to remove BsmBI site. 1279 
c1-16 and 855-890 from A/mallard/New York/6750/1978(H2N2) (M80945.1). 1280 
d1-26 and 882-890 from A/tufted duck/Mongolia/1409/2010(H1N1) (KC871435.1). A696C to remove BsmBI site. 1281 
e1-15 and 871-890 from A/guinea fowl/New York/20221-11/1995(H2N2) (CY014833.1). 1282 
1283 
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Table 2 – Independent introductions of avian B-allele NS segments into 1284 
mammalian hosts  1285 
 1286 
Strain Host Transmission Notes Accession 
(NS) 
Avian 
Source 
      
A/equine/Jilin/1/1989 (H3N8) Equine Epidemic Major equine 
influenza epidemic 
(25) 
M65020 Domestic 
A/muskrat/Buryatiya/1944/2000 
(H4N6) 
Muskrat Single isolate Closely related to 
H4N6 avian influenza 
circulating in Russia 
at similar time point 
(70).  
GU052363.1 Wild 
A/swine/KU/16/2001(H7N2) Swine Likely single 
isolate 
Isolated from 1 pig 
(532 tested) from a 
slaughterhouse. 
Apparent 
reassortment 
between avian H7N2 
and H5N3 viruses 
(71). 
CY067690 Domestic 
A/swine/Saskatchewan/18789/02 
(H1N1) 
Swine Likely 
transmissible 
in pigs 
Isolated from a 1200 
sow pig farm where 
influenza-like 
symptoms affected 
pigs of all ages. Fully 
avian virus. (72) 
AY619957 Wild 
A/New York/107/2003 (H7N2) Human Single isolate Apparent individual 
infection of a 48-
year-old 
immunocompromised 
man from the 
Caribbean with fever 
and flu-like 
symptoms. No 
apparent 
transmission to 
family. (73) 
EU587374.2 Domestic 
A/swine/Korea/C13/2008 (H5N2) Swine Apparent 
transmission 
Serological evidence 
of transmission within 
pigs (maybe 
asymptomatic?) (74) 
FJ461601.1 Wild 
1287 
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Table 3 – Independent introductions of avian A-allele NS segments into 1288 
mammalian hosts 1289 
 1290 
Prototypic Strain Host Transmission Notes Accession 
(NS) 
Avian Source 
A/Brevig Mission/1/1918 
(H1N1)  
Human Pandemic Persists through 
classical swine, human 
H2N2, H3N2 and 
pdm2009 lineages 
AF333238.1 Undetermined 
A/equine/Prague/2/1956
(H7N7) 
Equine Transmissible Likely to be extinct.  CY087820 Undetermined 
A/equine/Miami/1/1963 
(H3N8) 
Equine Transmissible Major circulating equine 
influenza A virus. Also 
endemic in US domestic 
dogs (canine H3N8).  
CY028840 Wild 
A/swine/China/8/1978 
(H3N2) 
Swine Circulating in 
pigs 
Kawaoka et al suggest 
this belongs in Eurasian-
avian lineage that is 
circulating in European 
pigs (75). 
M80968 Domestic 
A/swine/Belgium/WVL1/
1979(H1N1) 
Swine Transmissible Representative isolate 
for ‘Eurasian swine flu’  
 
CY037902 Domestic 
A/seal/Massachusetts/1
/1980(H7N7) 
Seal Epidemic in 
seals 
Epidemic in seals with 
approximately 600 
fatalities. (76) 
AB284067 Wild 
A/seal/Massachussetts/
133/1982(H4N5) 
Seal Epidemic in 
seals 
1983 outbreak in which 
60 seals were reported 
dead. 39 were positive 
for an H4N5 
indistinguishable from 
the prototype virus  (77) 
M80947 Wild 
A/mink/Sweden/3900/ 
1984(H10N4) 
Mink Outbreak in 
Mink 
One of the first identified 
cases of avian influenza 
able to transmit readily 
in mammalian host (78) 
GQ176140 Domestic 
A/whale/Maine/328B/19
84(H13N2) 
Whale Single isolate Isolated from one sick 
pilot whale, no evidence 
of a transmission chain. 
(79). 
KJ372724 Wild 
A/seal/Massachusetts/3
911/1992 (H3N3) 
Seal Likely 
transmissible 
Two closely related 
H3N3 viruses were 
detected in three seals 
following an increase in 
the number of stranded 
seals in Cape Cod in 
1992 (80).  
GU052287 Wild 
A/swine/Hong 
Kong/644/1993(H1N1) 
Swine Possible 
transmission. 
3 independent H1N1 
isolates from pigs with 
closely related NS 
segments, transmission 
information not 
disclosed in publication 
(81).  
CY085013 Domestic 
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A/England/AV877/1996 
(H7N7) 
Human Likely single 
isolate 
Isolated from 43-year-
old duck farmer with 
mild one-sided 
conjunctivitis (82) 
GU053113 Domestic 
A/swine/Eire/89/1996(H
1N1) 
Swine Single isolate No other closely related 
isolates of same 
subtype, host and year.  
(83) 
CY115892 Domestic 
A/Hong 
Kong/482/97(H5N1) 
Human Individuals 
only. 
Includes related H9N2 
human and swine 
isolates in China 1997-
2010. 
AF084285 Domestic 
A/Swine/Ontario/01911-
1/99 (H4N6) 
Swine Likely 
transmission 
Outbreak in pigs with 
pneumonia in Canada 
(84) 
AF285889 Wild 
A/swine/KU/2/2001(H11
N6) 
Swine Possible 
transmission 
No published 
information available. 4 
independent H11N6 pig 
isolates from same year 
and location suggests 
ability to transmit within 
pigs.  
CY073456 Domestic 
A/swine/Ontario/K01477
/01(H3N3) 
Swine Likely 
transmission 
Same H3N3 virus was 
isolated from more than 
one pig in a sick group 
(exact numbers not 
disclosed) (72) 
AY619965 Wild 
A/Caspian 
seal/Russia/1884/2002 
(H4N6) 
Seal Possible 
transmission? 
Two H4N6 isolates from 
Caspian Seals in Russia 
10 years apart with very 
closely related NS 
segments. Nothing 
published for these 
strains. 
KJ847690 Wild 
A/Netherlands/033/03 
(H7N7) 
Human Poorly 
transmissible 
between 
humans 
Mostly independent 
transmission events 
from birds to humans. 
H7N7 virus was 
epidemic in poultry in 
Netherlands in 2003 
(85). H7N7 IAV was 
detected in 85 subjects, 
with 3 people from within 
a household (86, 87). 
AY342423 Domestic 
A/Beijing/01/2003 
(H5N1) 
Human Not 
transmissible 
in humans? 
H5N1 ‘Bird Flu’. Human 
to human transmission 
is rare or non-existent. 
EF587281.1 Domestic 
A/Canada/rv504/2004 
(H7N3) 
Human Likely single 
isolates. 
Infection of two poultry 
workers on different 
farms during H7N3 
poultry outbreak in 
British Columbia, 
Canada (88) 
CY015010 Domestic 
A/swine/Korea/S452/20
04(H9N2) 
Swine Likely single 
isolates 
Two independent 
isolates of H9N2 swine 
viruses with very similar 
NS genes in 2004. 
Nature of infections not 
specified in literature 
(89).  
AY790309 Domestic 
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A/canine/Guangdong/1/
2006(H3N2) 
Canine Transmissible Avian H3N2 adapted to 
canine host and 
transmits well in 
population.  
GU433352 Wild 
A/swine/Hubei/10/2008 
(H10N5) 
Swine Transmissible 
in pigs 
Wholly avian virus, 
closely related to 
Eurasian swine IAV. (90) 
JX500447 Domestic 
A/swine/Jilin/37/2008 
(H3N2) 
Swine Likely single 
isolate 
Authors sampled 279 
sick pigs and this was 
isolated from one pig 
only. Has M and NS 
genes from H10 avian 
influenza (91) 
GU215038 Wild 
A/swine/Yangzhou/080/
2009(H6N6) 
Swine Likely 
transmissible 
in pigs 
Detected from clinical 
samples, co-infection 
with porcine circovirus 
type 2 in six pigs (92). 
Closely related to 
A/swine/Guangdong/K6/
2010(H6N6).  3.6% of 
475 sick pigs sampled 
were seropositive 
against H6 IAV (93). 
JQ815882 Domestic 
A/swine/HuBei/06/2009 
(H4N1) 
Swine Single isolate Apparent direct avian-to-
pig infection without 
chain of transmission. 
First H4 avian virus 
detected in pigs (94).  
JX878679 Wild 
A/swine/Guangdong/K4/
2011(H4N8) 
Swine Possibly 
transmissible 
in pigs 
Isolated from a pig in a 
group displaying 
respiratory symptoms 
(H4N8 and H3N2). (95) 
JX151011 Domestic 
A/harbor 
seal/Massachusetts/1/2
011(H3N8) 
Seal Probable 
transmission 
126 seals died from this 
outbreak of virus (96) 
JQ433883 Wild 
A/Mexico/InDRE7218/2
012 (H7N3) 
Human Likely single 
isolates 
High-pathogenicity 
H7N3 virus isolated from 
Mexican poultry workers 
with conjunctivitis in 
2012 (97). Likely direct 
infection from infected 
poultry. Similar NS 
segment to 
A/Canada/rv504/2004(H
7N3) (CY015010) (98) 
CY125732 Domestic 
A/Jiangxi/IPB13/2013 
(H10N8) 
Human Likely single 
isolates 
Human H10N8 cases 
likely from live poultry 
markets in China (99). 
Closely related to the 
H7N9 ‘precursor’ H9N2 
strains. 
KJ406559 Domestic 
A/Nanjing/1/2013 
(H7N9) 
Human Poorly 
transmissible 
in humans  
2013 and onwards 
H7N9 zoonotic episodes 
in China. 
KC896778 Domestic 
      
 1291 
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Table 4 - Expected number of avian B-allele introductions. Calculated using data from A-alleles, assuming a binomial distribution. Figures 1292 
in brackets represent the range of episodes that would still be statistically non-significant (p-values >=0.1)  1293 
Data A-allele B-allele Fisher test 
 Number of 
avian 
strains 
Number of 
independent 
introductions 
Introduction rate  Number 
of avian 
strains 
Number of 
independent 
introductions 
Introduction rate  p-value Expected number of B-allele 
introductions 
All avian 9617 32 0.0033 2717 6 0.0022 0.436 9.04 (4-15) 
Transmissible 9617 19 0.0020 2717 3 0.0011 0.446 5.37 (0-10) 
Single isolates 
or poor 
transmission 
9617 13 0.0014 2717 3 0.0011 1.000 3.67 (0-8) 
Domestic only 4391 18 0.0041 648 3 0.0046 0.756 2.66 (0-6) 
Wild only 5168 12 0.0023 2053 3 0.0015 0.578 4.77 (1-9) 
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Figure Legends 1294 
 1295 
Fig 1. Protein synthesis by NS segment reassortant viruses in mammalian cell 1296 
culture. MDCK cells were infected at an MOI of 3 and cell lysates were prepared at 8 h 1297 
p.i. To detect viral NP, NS1, M1 and M2 polypeptides as well as cellular tubulin, lysates 1298 
were subjected to SDS-PAGE and immunoblotted with the appropriate antisera. To 1299 
detect NEP protein, cells were infected at an MOI of 10 and metabolically labelled with 1300 
35S protein labeling mix between 6 h and 8 h p.i. Lysates were then immunoprecipitated 1301 
with anti-NEP antiserum and precipitates analysed by SDS-PAGE and autoradiography. 1302 
Data are representative of more than one independent experiment.  1303 
 1304 
Fig 2. A- and B- allele reassortant viruses replicate efficiently in mammalian cell 1305 
culture. (A, B) MDCK cells were infected at an MOI of 0.001 with PR8-based viruses 1306 
and the supernatants titrated by plaque assay (A) after 48 h or (B) at the plotted time-1307 
points. Data in (A) are the mean +/- SD (n = 5) while (B) is a single experiment. (C) 1308 
A549 cells were infected at an MOI of 0.001 with the indicated viruses and endpoint 1309 
titres determined after 48 h. Data are the mean +/- range (n = 2). (D) The replication 1310 
kinetics of PR8 NS segment reassortants in A549 cells were determined as described in 1311 
(B). Data are the mean +/- SD (n = 3). (E) Primary human CD14+ MDM cells were 1312 
infected with PR8-based viruses at an MOI of 3 and supernatant titres determined after 1313 
24 h. Data are the mean +/- range (n =2). A duplicate sample of PR8-infected cells was 1314 
taken immediately after the virus adsorption period (“post wash”) and titred to confirm 1315 
that the later samples reflected true virus replication and not carry over of virus 1316 
inoculum. (F) As in (A and B) and data represent mean +/- range (n = 2). (G) MDCK-1317 
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SIAT cells were infected at an MOI of 0.01 with Cal7-based viruses and the supernatant 1318 
titrated at the plotted time-points. Data are the mean +/- range (n = 2). (H) MDCK cells 1319 
were infected with Udorn72-based viruses as in (B). Data represent mean +/- range (n = 1320 
2). Dotted lines indicate the limit of detection.  1321 
 1322 
Fig 3. A B-allele reassortant is not deficient in controlling the host IFN response 1323 
in mammalian cell culture. (A, B) Ability of viruses to replicate despite established 1324 
antiviral conditions. A549 cells were pre-treated with varying concentrations of human 1325 
recombinant IFN-β for 24 h prior to infection with the indicated PR8 viruses at an MOI of 1326 
0.01. (A) Virus in the supernatant was titrated by plaque assay at 24 – 48 h p.i.. Data 1327 
are the mean titres from 24 h and 48 h multicycle infections. (B) Cell lysates were 1328 
prepared at 48 h p.i., subjected to SDS-PAGE, and immunoblotted for cellular IFN-1329 
inducible Mx-1, viral NP, and tubulin. (C-E) Induction of host cell type I IFN response 1330 
during infection with reassortant viruses. (C) Human lung A549 cells were infected for 1331 
24 h at varying multiplicity, and active type I IFN in the supernatant was quantified using 1332 
the HEK-Blue reporter cell-line. (D, E) As in (C) but MOI 3. 1333 
 1334 
Fig 4. Induction of host innate immune response during infection with reassortant 1335 
viruses. (A) Human CD14+ MDMs were infected at an MOI of 1 for 24 h and the levels of 1336 
various cytokines and chemokines in the supernatant determined using an immuno 1337 
spot-blot array. Values represent a heat map of mean fold-change with respect to a 1338 
mock-infected sample. (B, C) A549 cells were infected at an MOI of 5, cell lysates 1339 
generated at the indicated times and polypeptide composition determined by TMT-1340 
based quantitative mass spectrometry. (B) Values represent a heat map of mean fold 1341 
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change with respect to mock-infected samples. The zoomed portion shows a sub-1342 
cluster of heavily up-regulated antiviral proteins. (C) Quantitative temporal expression of 1343 
specific antiviral restriction factors Mx-1, IFIT2, OASL, IFIT3, IFIT1 and IFIH1 is plotted.   1344 
 1345 
Fig 5. Relative fitness of PR8 reassortant viruses. (A) Establishment of a strain-1346 
specific RT-PCR assay for A- and B-allele viruses. Viral RNA was extracted following 1347 
plaque purification of either O175A, O265B or (as examples) 2 unidentified viruses 1348 
obtained from co-infection with both and analysed by RT-PCR with primers specific for 1349 
the NS segment of either Ohio175A and Ohio265B was performed. (B) MDCK cells 1350 
were co-infected at an MOI of 0.001 (each) with the indicated mixtures of viruses and at 1351 
48 h p.i. the supernatant was analysed by plaque assay. 25 plaques were scored for the 1352 
proportion of progeny and a further portion of the original supernatant passaged further 1353 
at an MOI of 0.001. (C) MDCK cells were infected at an MOI of 3 per virus and the 1354 
proportion of each virus in the supernatant was assessed after 16 h (mean + SEM for A 1355 
v B, n = 3). (D) 5 BALB/c mice were co-infected with 250 PFU each of Ohio175A and 1356 
Ohio265B. At day 6 p.i., the left lung of each mouse was harvested and the proportion 1357 
of each virus in the lung homogenate was determined by plaque purification of 12 1358 
plaques and RT-PCR.  1359 
 1360 
Fig 6. Pathogenicity of PR8 reassortant viruses in BALB/c mice. (A) Five BALB/c 1361 
mice, per group, were nasally inoculated with 500 PFU of virus or mock-infected with 1362 
media and their weight was measured every 24 h. Data represent mean +/- SD. 1363 
Asterisks indicate statistical significance at day 6 post-infection, when all animals were 1364 
euthanized. (B) The left lung of each mouse was harvested at either day 2 or day 6 p.i. 1365 
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and virus in the homogenate was titrated by plaque assay. (C) Intracellular NP staining 1366 
in infected mouse lung. Lung sections from mice at day 2 p.i. were stained for viral NP 1367 
(red) and DNA (blue) and imaged using confocal and differential interference contrast 1368 
(DIC) microscopy. * p< 0.05; ** p<0.01, *** p< 0.005 in unpaired t-tests. 1369 
 1370 
Fig 7. Host responses to A- and B-allele segment 8 reassortant viruses. (A) At day 1371 
6 p.i., the right lung lobes of inoculated mice were collected, fixed, processed, and 1372 
stained with hematoxylin and eosin. Mock infected mice showed no significant changes, 1373 
whereas infected mice showed degeneration and necrosis of epithelial cells lining 1374 
airways with peribronchiolar and perivascular inflammation, and interstitial inflammation 1375 
sometimes accompanied by necrosis and fibrin accumulation. The inflammatory infiltrate 1376 
was predominately lymphocytes and macrophages with variable numbers of neutrophils. 1377 
Scale bars are 50 µm. (B). Severity of pathology in the lung was assessed blind and an 1378 
overall pathology score out of 3 was assigned. (C) RNA was extracted from lungs of 1379 
infected mice at day 4 p.i. and levels of various cytokines, chemokines, and antiviral 1380 
gene expression were quantified using RT-qPCR. Data are plotted as mean (20- dCT) 1381 
+/- SD. All infected samples were significantly different from the mock-infected sample, 1382 
unless labelled with ‘NS’ which indicates no significant difference in unpaired t-test. * p< 1383 
0.05; ** p<0.01. (D) The levels of various cytokines and chemokines in pooled lung 1384 
homogenates from groups of 5 mice culled at day 4 p.i. were determined using an 1385 
immunoblot spot array. Values are represented by a heat map of fold-change with 1386 
respect to mock-infected samples.  1387 
 1388 
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Fig 8. Major lineages of influenza A virus segment 8. Phylogenetic tree of a sub-1389 
sample of all influenza A virus segment 8 sequences, with major lineages highlighted in 1390 
colour.  1391 
 1392 
Fig 9. Mammalian B-allele segment 8 sequences. Phylogenetic tree of all avian allele 1393 
B lineage segment 8 sequences with the non-avian sequences highlighted.  1394 
 1395 
Fig 10. Distribution of avian segment 8 sequences. The host distribution and location 1396 
of isolation is represented for all avian A- and B-allele segment 8 sequences.  1397 
 1398 
 1399 
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